Semasize Solution for Injection (1 Multi-dose Disposable Pen, 4 Needle, 4 Alcohol Swab)
Semasize Injection contains Semaglutide, a GLP-1 receptor agonist used to support blood sugar management in adults with type 2 diabetes and assist with weight management when combined with a healthy diet and lifestyle. It works by improving insulin response, reducing appetite, and slowing stomach emptying.
Product Overview
Semasize Injection contains Semaglutide, a medicine belonging to the class of GLP-1 receptor agonists. It works by mimicking the action of a naturally occurring hormone called GLP-1 (glucagon-like peptide-1), which plays an important role in blood sugar regulation and appetite control. Semaglutide helps increase insulin release when blood sugar levels are elevated, reduces the release of glucagon (a hormone that increases blood sugar), and slows the movement of food through the stomach. These actions help improve glucose control and may support weight reduction by reducing hunger and calorie intake.
Product Composition
- Semaglutide – Active ingredient
- GLP-1 receptor agonist
- Incretin-based therapy
Product Specification
| Parameter | Details |
| Active Ingredient | Semaglutide |
| Medicine Class | GLP-1 Receptor Agonist |
| Dosage Form | Injectable Solution |
| Main Action | Improves insulin response and appetite regulation |
| Therapeutic Use | Type 2 diabetes and weight management |
Key Benefits
- Helps manage blood sugar levels:
Semaglutide improves insulin activity and supports better glucose control. - Supports weight management:
It helps reduce appetite and calorie intake, supporting gradual weight reduction. - Improves insulin response:
It helps the body release insulin more effectively when blood sugar levels rise. - Reduces hunger cravings:
Semaglutide acts on appetite pathways to support better control of food intake. - Supports heart health in suitable patients:
GLP-1 receptor agonists may provide cardiovascular benefits in certain individuals with diabetes. - Provides long-lasting action:
Semaglutide has a long duration of activity, allowing convenient dosing schedules.
Precaution
| Condition / Situation | Precaution |
| Pancreas problems | Inform your healthcare provider about any history of pancreatitis or pancreatic conditions |
| Gallbladder problems | Semaglutide may increase the risk of gallbladder-related issues in some individuals |
| Kidney problems | Dehydration from vomiting or diarrhoea may affect kidney function |
| Pregnancy | Discuss use before pregnancy or if planning to become pregnant |
| Stomach or digestion problems | Use cautiously in people with severe stomach problems |
Important Precaution Points
- Use Semasize Injection according to the recommended dose and injection schedule.
- Follow proper injection techniques and rotate injection sites to reduce skin irritation.
- Maintain adequate fluid intake, especially if experiencing nausea, vomiting, or diarrhoea.
- Inform your healthcare provider about diabetes medicines, digestive problems, or thyroid-related conditions.
Side Effects
Common Side Effects
- Nausea:
Feeling of sickness is one of the most common effects, especially when starting treatment. - Vomiting:
Some people may experience vomiting or stomach discomfort. - Diarrhoea:
Changes in bowel movements may occur during treatment. - Constipation:
Slower digestion may lead to constipation in some individuals. - Reduced Appetite:
Lower hunger levels are an expected effect of Semaglutide.
Less Common Side Effects
- Stomach pain or bloating
- Indigestion
- Injection site reactions
- Tiredness
- Dizziness
Serious Side Effects
| Condition | Detail |
| Severe allergic reaction | Rash, facial swelling, breathing difficulty, or severe sensitivity may occur rarely |
| Low blood sugar (Hypoglycaemia) | More likely when used with insulin or certain diabetes medicines |
| Kidney problems | Dehydration from severe vomiting or diarrhoea may affect kidney function |
Important Side Effects
- Mild nausea, constipation, or diarrhoea may occur and often improves as the body adjusts.
- Reduced appetite is a common effect that supports weight management goals.
- Temporary stomach discomfort or bloating may occur during the initial treatment period.
- Injection site redness or irritation may occur and is usually manageable.
Interaction
| Medicine / Substance | Possible Effect |
| Insulin | May increase the risk of low blood sugar when combined |
| Sulfonylureas | May increase the risk of hypoglycaemia |
| Oral medicines | Slower stomach emptying may affect absorption of some medicines |
| Warfarin and blood thinners | Monitoring may be needed as changes in absorption can occur |
| Diabetes medicines | Blood sugar-lowering effects may become stronger |
Important Interaction Advice
- Insulin and diabetes medicines:
Semaglutide may enhance blood sugar-lowering effects, so monitoring may be needed to avoid low blood sugar. - Medicines taken by mouth:
Since Semaglutide slows stomach emptying, it may affect how quickly some oral medicines are absorbed. - Other weight-loss or GLP-1 medicines:
Avoid combining similar medicines unless specifically advised. - Blood thinner medicines:
Inform your healthcare provider if you take anticoagulants, as medicine absorption and monitoring may need attention.
| Manufacturer | : | Alkem Laboratories Ltd |
| Trade Name | : | Ozempic |
| Generic Search | : | Semaglutide |
| Strength | : | 1mg, 2mg |
Latest Products
